Nininger Medical, founded in 2019, is dedicated to developing life-saving medical devices for patients suffering from structural heart failure. The company's core mission is to advance transcatheter heart valve therapies, particularly focusing on a transcatheter tricuspid valve replacement (TTVR) device utilizing proprietary 3D thin film technology. Nininger Medical aims to address the needs of millions of patients globally who are affected by heart valve diseases.
Notably, Nininger Medical received a Small Business Innovation Research (SBIR) grant from the National Science Foundation in December 2020, highlighting its innovative approach and potential impact. The company’s achievements in medical device development have positioned it as a significant player in the healthcare technology sector, contributing to advancements in heart valve therapies and improving patient outcomes.